Claus Henrik Nielsen

Claus Henrik Nielsen

Professor

ORCID: 0000-0001-7543-9016

Publication year:
All
1 - 14 out of 14Page size: 500
  1. 2008
  2. Published

    Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trialsTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    Banga, J. P., Gilbert, J. A., El, F. D., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Thyroid. 18, 9, p. 973-981 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    B-lymfocytdepletring og andre biologiske behandlingsmuligheder ved Graves' oftalmopatiTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    El, F. D., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Ugeskrift for læger. 170, 24, p. 2128-2130 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cellsTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    Baslund, B., Gregers, J. & Nielsen, Claus Henrik, 2008, In: Rheumatology.(Oxford). 47, 4, p. 451-453 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

    Fassi, Daniel El , Banga, J. P., Gilbert, J. A., Padoa, C., Hegedüs, L. & Nielsen, Claus Henrik, 2008, In: Clinical Immunology. 130, 3, p. 252-8 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    El, F. D., Kjeldsen, J., Clemmensen, O., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Gut. 57, 5, p. 714-715 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells

    Baslund, B., Gregers, J. & Nielsen, Claus Henrik, 1 Apr 2008, In: Rheumatology. 47, 4, p. 451-3 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease

    Fassi, Daniel El , Nielsen, Claus Henrik, Kjeldsen, J. B., Clemmensen, O. & Hegedüs, L., 1 May 2008, In: Gut. 57, 5, p. 714-5 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Enhancement of human adaptive immune responses by administration of a high-molecular-weight polysaccharide extract from the cyanobacterium Arthrospira platensis

    Løbner, M., Walsted, A., Larsen, R., Bendtzen, K. & Nielsen, Claus Henrik, 1 Jun 2008, In: Journal of Medicinal Food. 11, 2, p. 313-22 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Biologiske behandlingsmuligheder ved Graves' oftalmopati

    Fassi, Daniel El , Nielsen, Claus Henrik & Hegedüs, L., 9 Jun 2008, In: Ugeskrift for Laeger. 170, 24, p. 2128-30 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Nye behandlinger af Graves' sygdom med fokus på det B-lymfocyt-depleterende antistof rituximab

    Nielsen, Claus Henrik, Fassi, Daniel El & Hegedüs, L., 9 Jun 2008, In: Ugeskrift for Laeger. 170, 24, p. 2131-4 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials

    Banga, J. P., Nielsen, Claus Henrik, Gilbert, J. A., Fassi, Daniel El & Hegedus, L., 1 Sep 2008, In: Thyroid. 18, 9, p. 973-81 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis*

    Nielsen, Claus Henrik, Brix, T. H., Gardas, A., Banga, J. P. & Hegedüs, L., 1 Oct 2008, In: Clinical Endocrinology. 69, 4, p. 664-8 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

    Hedegaard, C. J., Krakauer, M., Bendtzen, K., Lund, H., Sellebjerg, Finn Thorup & Nielsen, Claus Henrik, 1 Oct 2008, In: Immunology. 125, 2, p. 161-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis

    Hedegaard, C. J., Krakauer, M., Bendtzen, K., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Nielsen, Claus Henrik, 1 Oct 2008, In: Clinical Immunology. 129, 1, p. 80-9 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 927479